BACKGROUND The early onset of menopause is associated with increased risks of
cardiovascular disease and osteoporosis. As a woman's circulating anti-Müllerian hormone …

Anti-Müllerian hormone (AMH) is a peptide belonging to the transforming growth factor beta
superfamily and acts exclusively through its receptor type 2 (AMHR2). From the 8th week of …

Background Censorship is the primary challenge in survival modeling, especially in human
health studies. The classical methods have been limited by applications like Kaplan–Meier …

Context Predicting the onset of menopause is important for family planning and to ensure
prompt intervention in women at risk of developing menopause-related diseases. Objective …

The human ovarian reserve is defined by the number of non-growing follicles (NGFs) in the
ovary, with the age-related decline in NGF population determining age at menopause for …

Background Antimüllerian hormone, the most reliable biomarker of ovarian reserve, is
widely used in various clinical situations. Antimüllerian hormone levels consistently …

This study aimed to assess an eligible cut-off value of anti-Müllerian hormone (AMH) to
detect ovarian senescence in a group of premenopausal Greek women to evaluate the …

Aim To present evidence‐based recommendations for anti‐Müllerian hormone (AMH)
measurement as an ovarian reserve test. Methods A systematic literature search for the …

Background While the phenotypic association between anti-Müllerian hormoneand age at
menopause has been widely studied, the role of anti-Müllerian hormone in predicting the …

Background: It is well documented that menopause is linked to an increased risk of
cardiovascular (CV) events; however, the results of studies focusing on the association …